Normally, MMP activity is closely regulated by tissue inhibitors, e.g., TIMPs [86]; in cancer, dysregulated MMP-TIMP expression may favor proteolysis [86], thereby contributing to cancer spread [87]. This evidence concerns the gene TIMP1 and cancer.